Insiders · NEO

William Bonello

Officer at Neogenomics Inc (NEO)

William Bonello has filed 8 insider reports with the SEC since March 2021, as officer at Neogenomics Inc (NEO). William Bonello made no open-market purchases or sales in the last 12 months. The latest filing, on May 2, 2022, reports exercise or conversion of a derivative at Neogenomics Inc (NEO).

Filings
8
Companies
1
Bought on market
None
Sold on market
$987K

Companies where William Bonello is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Neogenomics Inc logo
NEO
Neogenomics Inc
Officer191,548$987K$14.82May 2, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare William Bonello with

Other insiders at the same companies

Questions about William Bonello

What is William Bonello's role at Neogenomics Inc?
William Bonello reports to the SEC as officer at Neogenomics Inc (NEO), according to the latest filing on May 2, 2022.
How many shares does William Bonello own?
After the latest filing that states it, William Bonello directly owned 191,548 shares of Neogenomics Inc (NEO). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has William Bonello bought or sold stock recently?
The most recent open-market sale was on March 8, 2022: sold 3,209 shares of Neogenomics Inc (NEO) for $58.7K at an average of $18.29.
How do I get alerts when William Bonello files?
Follow William Bonello on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by William Bonello (SEC CIK 0001454941). Totals count each trade once, skipping amendments whose original is on file, from Mar 4, 2021 on. View on SEC EDGAR · Get this as JSON